Furthermore, specifically cystatin C and interleukin-6 are not routinely measured in CS patients, whereas no distinct sub-analyses were performed regarding the prognostic role of cardiac biomarkers in CS [46]. This evidence concerns the gene CST3 and Cowden syndrome 1.